Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Tendal B et al. – Disagreements were common and often larger than the effect of commonly used treatments. Meta–analyses using SMDs are prone to observer variation and should be interpreted with caution. The reliability of meta–analyses might be improved by having more detailed review protocols, more than one observer, and statistical expertise.

Related Articles

A Population-based Study of Spinal Metastatic Disease in South-East Norway
Clinical Oncology, 11/12/09    Relevance Score: 80%

Magnesium and headache after aneurysmal subarachnoid haemorrhage
Journal of Neurology, Neurosurgery, and Psychiatry, 10/26/09    Relevance Score: 80%

Today in Drug Trials...keeping you current

ARIAD Announces Full Enrollment in Phase 3 Succeed Trial Evaluating Ridaforolimus in Patients with Metastatic Sarcomas
ARIAD Pharmaceuticals, 12/18/09

Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies
Investigational New Drugs, 12/18/09

Prognostic Factors in Idiopathic Pulmonary Fibrosis
The American Journal of the Medical Sciences, 12/17/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address